Literature DB >> 15785926

CD2-associated protein in human urogenital system and in adult kidney tumours.

Jukka Tienari1, Sanna Lehtonen, Eero Lehtonen.   

Abstract

We studied expression of CD2-associated protein (CD2AP) in human urogenital system and in adult kidney tumours. In the cortex of normal kidney, CD2AP was expressed in all types of tubules and in the glomeruli. Labelling was more intense in cytokeratin 7- and in Tamm-Horsfall-positive tubules than in proximal tubules. In the medulla, expression was observed in the collecting ducts. Urothelium and the epithelium of prostatic acini, seminal vesicles, seminiferous tubules, epididymal ducts, Fallopian tube, endometrium and endocervix as well as granulosa cells showed moderate to strong CD2AP positivity. In syncytiotrophoblast, the expression was weaker than in cytotrophoblast. Endometrial stroma was negative, but decidualised stroma was weakly positive. Clear cell renal cell carcinoma (RCC) (n=63) showed a weak expression. Type-I papillary RCCs (n=4) and papillary adenomas (n=3) were negative. The epithelium lining the cysts in multilocular cystic RCCs (n=3) and in cystic nephroma (n=1) was strongly positive. Chromophobe RCCs (n=2), oncocytomas (n=3) and urothelial carcinomas (n=2) were moderately positive. The results show that CD2AP displays a specific expression pattern in human urogenital organs and that distinct expression is shown in several types of kidney tumours but not in type-I papillary RCCs or in papillary adenomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785926     DOI: 10.1007/s00428-004-1166-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain.

Authors:  N Y Shih; J Li; R Cotran; P Mundel; J H Miner; A S Shaw
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 2.  Genetics and pathogenesis of polycystic kidney disease.

Authors:  Peter Igarashi; Stefan Somlo
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

3.  The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct.

Authors:  S Störkel; P V Steart; D Drenckhahn; W Thoenes
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

4.  Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease.

Authors:  A A Renshaw; J P Richie
Journal:  Am J Clin Pathol       Date:  1999-04       Impact factor: 2.493

5.  Prognostic significance of the Heidelberg classification of renal cell carcinoma.

Authors:  B Ljungberg; F I Alamdari; R Stenling; G Roos
Journal:  Eur Urol       Date:  1999-12       Impact factor: 20.096

6.  In vivo interaction of the adapter protein CD2-associated protein with the type 2 polycystic kidney disease protein, polycystin-2.

Authors:  S Lehtonen; A Ora; V M Olkkonen; L Geng; M Zerial; S Somlo; E Lehtonen
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

7.  Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma.

Authors:  X Leroy; D Moukassa; M C Copin; F Saint; E Mazeman; B Gosselin
Journal:  Eur Urol       Date:  2000-04       Impact factor: 20.096

8.  Targeted downregulation of extracellular nephrin in human IgA nephropathy.

Authors:  Elena Gagliardini; Ariela Benigni; Susanna Tomasoni; Mauro Abbate; Raghu Kalluri; Giuseppe Remuzzi
Journal:  Am J Nephrol       Date:  2003-07-09       Impact factor: 3.754

9.  Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.

Authors:  F Jiang; J Richter; P Schraml; L Bubendorf; T Gasser; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more
  1 in total

1.  Identification of CD2, CCL5 and CCR5 as potential therapeutic target genes for renal interstitial fibrosis.

Authors:  Chuanjie Zhang; Xin Hu; Feng Qi; Jun Luo; Xiao Li
Journal:  Ann Transl Med       Date:  2019-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.